Cargando…
Pharmacogenomic Approaches for Automated Medication Risk Assessment in People with Polypharmacy
Medication regimen may be optimized based on individual drug efficacy identified by pharmacogenomic testing. However, majority of current pharmacogenomic decision support tools provide assessment only of single drug-gene interactions without taking into account complex drug-drug and drug-drug-gene i...
Autores principales: | Liu, Jiazhen, Friedman, Carol, Finkelstein, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Informatics Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961823/ https://www.ncbi.nlm.nih.gov/pubmed/29888060 |
Ejemplares similares
-
Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study
por: Finkelstein, Joseph, et al.
Publicado: (2016) -
Potential utility of precision medicine for older adults with polypharmacy: a case series study
por: Finkelstein, Joseph, et al.
Publicado: (2016) -
Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
por: Schuh, Michael J., et al.
Publicado: (2021) -
Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021) -
Automated Detection of Patients at High Risk of Polypharmacy including Anticholinergic and Sedative Medications
por: Shirazibeheshti, Amirali, et al.
Publicado: (2023)